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GUREVITZ, O., ET AL.: Patients with an ICD Can Safely Resume Work in Industrial Facilities Follow-
ing Simple Screening for Electromagnetic Interference. Patients with ICDs are commonly advised to quit
industrial jobs because of concerns that strong electromagnetic fields operating in the industrial environ-
ment might interfere with ICD functions. This study was done to assess interactions between industrial
equipment and ICDs, and to devise a simple low risk screening protocol. We studied 18 patients carrying
nine different ICD models who were met at their workplace by a clinical technician and were asked to
walk through their workplace and perform typical duties while sensing status was monitored by listening
to the ICD’s beeper. All devices were interrogated at the completion of testing. At follow-up, patients were
contacted by phone and were asked about employment status and history of ICD discharges or syncope.
One hundred eighty-four contacts with 114 types of industrial equipment in 13 different industrial facili-
ties (including 31 contacts with arc welding machines) were monitored. Interference with ICD’s function
occurred in only one contact (0.5%), when ICD therapy was temporarily suspended while a worker was
attaching a huge electromagnet to a crane. At follow-up 46.0 ± 6.0 months after testing, 7 patients (41%)
are still holding the same job, 7 have retired because of reasons unrelated to their ICD, and 3 patients were
transferred to a nonindustrial job. None of the patients had either an ICD shock or syncope during work.
The use of a simple screening procedure can safely identify sources of electromagnetic interference that
may affect ICD operation, and can predict long-term safety of working in an industrial workplace for ICD
patients. (PACE 2003; 26:1675–1678)
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Introduction
Implantable cardioverter defibrillators (ICDs)
reduce mortality in patients with malignant ven-
tricular arrhythmias.1−5 However, ICDs can have
a negative impact on quality of life measures.6
One of the most important factors influencing the
quality of life after a medical intervention is the
ability to return to work.7 Patients with ICDs are
often advised to quit industrial jobs because of con-
cerns that strong electromagnetic fields operating
in the industrial environment might interfere with
the device’s normal function.
Electromagnetic interference (EMI) can alter
ICD’s function in several ways: (1) Electrical sig-
nals within the frequency range of the ICD’s sens-
ing circuitry can induce false detection of arrhyth-
mias and result in inappropriate therapy.8,9 (2)
Sensed external electromagnetic noise may pre-
vent detection of actual ventricular arrhythmias,
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preventing the delivery of lifesaving therapy.10 (3)
EMI can cause the defibrillator to revert to a “pro-
tection mode” changing its programmed parame-
ters to the default values.10 (4) A strong magnetic
field can close the reed switch of the device, caus-
ing it to be inhibited.11 The purpose of our inves-
tigation was to devise a simple, low risk screening
protocol that will help ICD patients, physicians,




The study group was comprised of 18 pa-
tients with ICDs (3 women) with a mean age of
51.4 ± 14.7 (range: 23–77) years. All patients re-
ceived an ICD because of documented sustained
ventricular arrhythmias, and none had a pacing
indication. Nine different models of ICD’s were
implanted (Table I). All ICDs were manufactured
by Guidant/CPI (St. Paul, MN, USA). The devices
used can be programmed to emit an audible tone
for each sensed QRS and a special tone if EMI is
sensed. This feature enables continuous monitor-
ing of the device’s sensing during daily activities














*All devices were manufactured by Guidant/Cardiac Pacemaker,
Inc., St. Paul, MN.
without the need to apply a magnet or suspend
therapy. Fourteen patients had pectoral implants.
All but one used a nonthoracotomy Endotak lead
system (Guidant/CPI).
Testing Procedure
The study involved three stages:
Stage 1: At baseline all devices were interrogated.
The magnet response was tested and the mark-
ers, magnet, and QRS beeper were enabled.
One to one sensing correlating QRS detection
and the beep tones were verified. Detection
duration was extended to 15 seconds for each
therapy zone while the ICD remained fully ac-
tive. We did not feel that it was safe to inacti-
vate ICD therapy without an external defibril-
lator immediately available, and thus chose to
extend the arrhythmia detection duration for
each therapy zone.
Stage 2: Each patient was asked to walk through
their workplace and operate each item of
equipment as they would during their usual
activities. The device’s QRS beeper was moni-
tored with a stethoscope by a clinical engineer
or nurse specially trained to work with ICDs.
Each item was recorded as well as the approx-
imate distance to the patient and the effects
on the device’s sensing. The engineer or nurse
was instructed to apply a magnet and remove
the patient from a source should oversensing
occur.
Stage 3: At the conclusion of testing, all pro-
grammed parameters were returned to their
initial values. The devices were interrogated
and final parameters were compared with the
initial values.
Follow-Up
Seventeen patients were contacted by phone
46 ± 6 months after initial testing. One patient was
lost to follow-up. Patients were asked to give de-
tails regarding current employment status, reasons
for retirement, and history of ICD shocks and syn-
copal spells during work. If a patient reported be-
ing shocked or experiencing syncope during work,
the relevant pacemaker clinic was contacted and
data regarding the event obtained.
Results
Testing Results
Between October 1995 and February 1998, 18
patients with ICDs requested testing in order to re-
sume 11 different job positions at 13 different in-
dustrial facilities (Table II). In these patients, 184
contacts with 114 different types of equipment
were recorded, including 31 with arc welding
machines. The distance measured between the pa-
tient and the equipment ranged from zero (touch-
ing in 5 patients) to 360 inches, with a mean of
24.8 ± 54.8 inches. In only one instance was
interference recorded when a worker in a steel
facility was responsible for attaching a huge elec-
tromagnet to a crane. In this patient ICD therapy
was temporarily inhibited while within 6 feet of
the electromagnet. He was advised to change jobs.
Table II.
Job Positions and Industrial Facilities
Patient’s
number Job position Facility type
1 Engineer Electrical automobile
factory
2 Jobsetter Auto assembly
3 Welder College
4 Production worker Automobile steel factory
5 Machinist Metal factory
6 Data processing Electrical company
7 Electrician Metal factory
8 Production worker Machinery shop
9 Production worker Welding
10 Production worker Metal factory
11 Production worker Steel factory
12 Welder Machinery shop




17 Radio operator Home
18 Machinist Machining plant
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Table III.
Follow-Up
Patient’s Age (years)*/ Length of follow-up Shocks/syncope
number sex (months) Current occupation at work
1 63/M 60 Retired No
2 45/F 59 Non-industrial No
3 29/M 58 Non-industrial No
4 45/M 57 Industrial No
5 76/M Lost to follow-up
6 23/F 51 Retired No
7 45/M 49 Industrial No
8 56/M 48 Industrial No
9 33/M 49 Non-industrial No
10 64/M 47 Industrial No
11 49/M 44 Retired No
12 45/M 42 Industrial No
13 62/F 39 Retired No
14 59/M 38 Retired No
15 52/M 38 Retired No
16 59/M 38 Retired No
17 77/M 33 Industrial No
18 44/M 32 Industrial No
Mean ± SD 51.4 ± 14.7 46.0 ± 9.0
*Age at the time of testing. SD = standard deviation.
There were no other cases of oversensing in the
other 183 contacts that were monitored. Similarly,
we did not observe any changes in the devices’ pro-
grammed parameters after any of these encounters.
Follow-Up
Follow-up data were obtained for 17 (94%)
patients 46.0 ± 9.0 (range 32–60) months after
testing (Table III). One patient was lost to follow-
up. At the time of follow-up, 7 (41%) patients
were still working in the same position they held
at the time of testing. Seven patients had retired
15.9 ± 10.0 months after testing. Reasons for re-
tirement included: congestive heart failure in two
patients, age, inner ear disease, cerebrovascular
event, asthma, and childbearing in one patient
each. Three patients changed to a nonindustrial job
5, 23, and 25 months after testing. Two of them said
that they preferred to avoid the industrial work-
place because they were concerned about poten-
tial interactions with their devices. None of them
reported being shocked or experienced loss of con-
sciousness while at work. During the follow-up
period, only one patient reported having an ICD
discharge while at work. Data obtained from his
pacemaker clinic revealed no shock episodes ac-
cording to the device’s interrogation, and repro-
duction of the same “shock” sensation occurred by
bending the head. The symptoms were attributed
to vertebral discopathy. This patient continued
to work as a welder at the time of follow-up 37
months after the reported “event.” No patient re-
ported syncope during work.
Discussion
Electromagnetic Interference in the Workplace
Interference of environmental electromag-
netic fields with the function of cardiac pace-
makers is well reported.12 Since ICDs became
widely used in the mid 1980s, several case reports
have described either the inappropriate delivery of
shocks 8,9 or the inactivation of devices by EMI.11
So far only few studies systematically addressed
the effects of EMI in the workplace on patients with
implanted devices. Marco et al.13 investigated 12
pacemaker patients in the industrial environment.
They found that arc welding machines delivering
up to 225 A did not adversely interfere with pace-
maker function. However, a submerged arc welder
using up to 1,000 A inhibited his pacemaker
when the pacemaker was within 15 centimeters
of the welding site. In a recent study, Fetter
et al.14 interrogated ICDs of 11 patients immedi-
ately after they had operated different arc weld-
ing machines or were working near high power
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motors. In none of their cases did oversensing oc-
cur. Our findings are in agreement with these data.
During routine work in industrial facilities, we
were able to record oversensing by an ICD in only
one of 184 encounters (0.5%). We did not detect
any reprogramming or reed switch closure. Differ-
ing from previous studies, we provide long-term
follow-up. Our follow-up results help support the
findings of initial testing and provide evidence
for the reliability of our testing protocol. All but
one patient were allowed to return to their previ-
ous work after testing. None of them had ICD dis-
charges or syncope during work, and 46 months af-
ter testing, 41% of them still work in the industrial
setting.
Factors Influencing Interference
The main factors determining whether an
electromagnetic source will interfere with an ICD’s
functions are the frequency of the emitted electri-
cal signals, the magnitude of the magnetic field,
and the spatial orientation and proximity of the
source to the device. Because one of our goals was
to devise a simple and practical way of screen-
ing, we did not measure the electromagnetic fields
operating in our patients’ workplaces. However,
Fetter et al.14 recorded the power rating of electri-
cal equipment very similar to that used by our pa-
tients. According to their report, AC arc welders
use from 2 to 375 A while DC arc welding ma-
chines use up to 900 A. The magnetic flux density
they measured at the surface of cables or motors
ranged between 40 and 2,530 G and decreased to
0.5 to1.2 G at a distance of 1 to 2 feet from the sur-
face. The minimal magnet field that is required to
cause reed switch closure (i.e, inactivation) of an
ICD is 10 G. No oversensing occurred when ICD pa-
tients were instructed to keep a minimal distance
of 1 foot from the equipment they were using.14 In
contrast, we did not instruct our patients about the
distance they should keep from their equipment,
but instead recorded the actual distance they kept
during usual daily tasks. With an average distance
of 24.8 ± 54.8 inches (ranging 0-360 inches) no
oversensing was recorded during 183 of 184 con-
tacts monitored. ICD therapy was temporarily sus-
pended at a distance of up to 6 feet from a very
powerful electromagnet in one patient.
Study Limitations
One limitation of our study is that devices
from only one manufacturer (CPI/Guidant) were
assessed. It is possible that other ICDs and lead
systems might respond differently. Also, electro-
magnetic fields in a specific workplace may change
over time because of wear and tear or the replace-
ment of machines. A change in the patient’s dis-
tance from a machine or mode of operation can
also influence the probability of EMI. Thus, alter-
ations in the workplace may warrant a new testing
procedure.
Conclusions
Our findings suggest that patients who receive
an ICD, typically can resume work in industrial fa-
cilities after appropriate individual testing is per-
formed. In the event that the patient experiences
lightheadedness or a shock, they must be removed
immediately from the source and seek medical
evaluation. Any change made in the equipment
operated by the patient or in their ICD warrants
retesting for possible interactions.
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